"10.1371_journal.pone.0151770","plos one","2016-03-28T00:00:00Z","Eduardo B Bermudez; Elizabeth B Klerman; Charles A Czeisler; Daniel A Cohen; James K Wyatt; Andrew J K Phillips","Morehouse School of Medicine, Atlanta, Georgia, United States of America; Division of Sleep and Circadian Disorders, Brigham and Womens Hospital and Harvard Medical School, Boston, Massachusetts, United States of America; Sentara Healthcare, Norfolk, Virginia, United States of America; Rush University Medical Center, Chicago, Illinois, United States of America","Conceived and designed the experiments: DAC JKW EBK CAC. Performed the experiments: EBK DAC JKW. Analyzed the data: EBB EBK DAC JKW AJKP CAC. Contributed reagents/materials/analysis tools: AJKP EBB. Wrote the paper: EBB EBK DAC JKW AJKP CAC.","The authors of this manuscript have the following competing interests: Dr. Klerman has received travel funds from Servier and the Sleep Technology Council. Dr. Phillips has consulted for Zeo, Inc. Dr. Wyatt has consulted for Phillips-Respironics. Dr. Czeisler has received consulting fees from: Amazon.com, Inc.; A2Z Development Center; Bose Corporation; Boston Celtics; Boston Red Sox; Cephalon, Inc.; Citgo Inc.; Cleveland Browns; Columbia River Bar Pilots; Jazz Pharmaceuticals; Koninklijke Philips Electronics, N.V.; Minnesota Timberwolves; Portland Trail Blazers; Samsung Electronics; Teva Pharmaceuticals; Valero Inc.; Vanda Pharmaceuticals. Dr. Czeisler has also received education/research support from Mary Ann & Stanley Snider via Combined Jewish Philanthropies, Philips Respironics, San Francisco Bar Pilots, and Vanda Pharmaceuticals, Inc. Dr. Czeisler is the incumbent of an endowed professorship provided to Harvard University by Cephalon, Inc. and holds a number of process patents in the field of sleep/circadian rhythms. Since 1985, Dr. Czeisler has also served as an expert on various legal cases related to sleep and/or circadian rhythms including those involving the following commercial entities: Bombardier, Inc.; Continental Airlines; FedEx; Greyhound; Purdue Pharma, L.P.; and United Parcel Service (UPS). Dr. Czeisler owns or owned an equity interest in Somnus Therapeutics, Inc. and Vanda Pharmaceuticals. He received royalties from Houghton Mifflin Harcourt/Penguin Press, and Philips Respironics, Inc. for the Actiwatch-2 and Actiwatch-Spectrum devices. Dr. Czeisler’s interests were reviewed and managed by Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict of interest policies. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2016","03","Eduardo B Bermudez","EBB",6,TRUE,4,3,6,6,TRUE,TRUE,FALSE,0,NA,FALSE
